LAS VEGAS, Oct. 25, 2017 (GLOBE NEWSWIRE) -- In 2012, the global Apheresis Equipment Market was valued around USD 1.21 billion and is projected to reach approximately USD 2.57 billion by 2022, registering a compound annual growth rate (CAGR) of 7.05% during the forecast period. Apheresis is a process of blood element separation with the help of membrane filtration or centrifugation technology. This process has existed since the 1950’s and is used for different blood component separation and blood purification purposes. The process is executed either for disease treatment by removing the disease-causing or diseased blood component or for blood component donation. Whole blood is drawn out from patient or donor’s body, refined by apheresis machine, and the preferred blood components are divided on the basis of their size, molecular weight, and resemblance to a specific material. The leftover blood is instilled back to patient or donor’s body. Apheresis processes are performed around the world for treatment of a variety of renal, neurological, autoimmune, hematological, and other disease.
The global apheresis market is anticipated to demonstrate lucrative growth while maintaining a significant compound annual growth rate over the projected period of 2012 to 2022. Rising prevalence of blood-related diseases contributing to the increase in plasma and platelets demand is anticipated to assist the global market as an eminent impact rendering and growth driving factor. The global apheresis market is also projected to be fueled by technological advancements aimed at rendering comparatively more quick and effective results. Healthcare researchers and practitioners now need devices which will require the least human intervention and the advent of completely automatic apheresis equipment with superior displays is anticipated to enhance application rates for this equipment and hence boosting the global apheresis market over the forecast period. Risk of blood infection, deficiency of experts to execute the process and inaccessibility of both specific blood group & donor are the factors which might hinder the growth of the global market over the next few years.
Get sample of this report: http://www.crystalmarketresearch.com/report-sample/HC10265
Market Players
- Terumo BCT Inc.
- Haemonetics Corporation
- Fresenius Kabi (Fenwal)
- Asahi Kasei Kuraray Medical Co. Ltd.
- B. Braun Melsungen AG
- HemaCare Corporation
- Therakos Inc.
According to the product type, the apheresis market is classified as; Apheresis machine and Disposable Apheresis kits. On the basis of the procedure, the global market industry is divided into; Plasmapheresis, Plateletpheresis, LDL-apheresis, Leukapheresis, Erythrocytapheresis, Photopheresis and Other Equipment. By application, the market is split as; Hematology, Renal Diseases, Neurology and Other Applications. Depending on the technology used, the market is split into; Centrifugation and Membrane Separation. Geographically, the global apheresis market is segmented into regions which are; Europe (Germany, Spain, Italy, France, UK and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and Rest of Asia Pacific), North America (the United States, Mexico and Canada) and Rest of the World (Brazil, Saudi Arabia, South Africa, United Arab Emirates and Others).
Buy Report: http://www.crystalmarketresearch.com/checkout/265
Key findings of the apheresis market
- Rising blood-related disease occurrences contributing to blood components demand and Advancements in apheresis techniques are the factors boosting the market growth while lack of skilled workers for performing process, blood infection risk, lack of donors, and unavailability of particular blood group are the restraints for market growth.
- Existence of high unfulfilled needs and speedily increasing requirements for platelets in the developing Latin American and Asia Pacific markets is anticipated to assist global market as potential growth opportunities.
- Key players of this industry include Fresenius Kabi; Haemonetics; Fresenius Kabi (Fenwal), Asahi Kasei Kuraray Medical Co. Ltd., B. Braun Melsungen AG, HemaCare Corporation, Therakos, Inc. Strategies encouraging rapid distribution and development of proficient supply chain are increasingly integrated by the market players.
About Us:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
Website: www.crystalmarketresearch.com